Tuesday, November 17, 2026

Brain Healthcare's medical AI/SaMD startup Splink receives the "Minister of Economy, Trade and Industry Commendation for Intellectual Property Merit Award"!

Splink, a medical AI startup in the field of brain healthcare, received the "Minister of Economy, Trade and Industry Award" as an intellectual property venture in the 2024 Intellectual Property Merit Awards!
This is the first time that Splink has received this award as a medical AI/SaMD* startup.
*Software as a Medical Device: Software and medical device programs for medical purposes that assist in the diagnosis and treatment of diseases.

About the IP Merit Award

The Intellectual Property Merit Awards are presented annually by the JPO of the Ministry of Economy, Trade and Industry to individuals who have contributed to the development, dissemination, and awareness of the intellectual property rights system, and to companies that have made effective use of the system and contributed to its smooth operation and development. Both awards are collectively referred to as the "Intellectual Property Merit Awards.

Splink's Intellectual Property Initiatives

Splink develops and provides one-stop medical device programs in the field of brain healthcare, including dementia, with consistent solutions from prevention to diagnosis, under the vision of "Connecting all people, until the day they become connected.

As a deep-tech startup, how do we create and distribute our core technologies? We have positioned intellectual property as an important management resource, just like people, products, and money, and have formulated and promoted intellectual property strategies from this perspective since the founding of the company. In order to realize this vision, we are proactively creating a framework for IP creation, including internal awareness-raising, by establishing a dedicated IP management team, holding regular meetings between the business and R&D divisions to share information, disseminating in-house IP columns and providing training, and collaborating with a patent attorney firm that specializes in various fields. We are actively creating a framework for IP creation, including internal awareness-raising activities.

In 2021, we won the Grand Prix of the 3rd IP BASE AWARD sponsored by the Japan Patent Office, which recognizes the best IP players in domestic startups, and the following year, in 2022, we won the Grand Prix of the 2022 WIPO Global Awards sponsored by the World Intellectual Property Organization (WIPO), the intellectual property organization of the United Nations (UN). The following year, in 2022, the company won the Grand Prix at the 2022 WIPO Global Awards sponsored by the World Intellectual Property Organization (WIPO), the intellectual property organization of the United Nations (UN). Following the domestic and international awards, this is the first time in our history that we have won three IP-related awards.

Key Points of the Award

The following three points were made about the awarding of the IP Merit Award.

1. The company is working on AI-based solutions that lead to prevention and early diagnosis in the field of brain healthcare, including dementia, from R&D to social implementation in a comprehensive manner. Since its establishment, the representative director has positioned intellectual property as an important management asset as well as human, material, and financial resources, and has led the construction of a strategic intellectual property portfolio with an awareness of the speed at which intellectual property can be distributed. In addition to filing applications for core and improved technologies, the company also utilizes divisional applications to build a patent network.

2. Promote IP strategies that are integrated with management and business strategies, such as using IP information to identify potential competitors, obtain uniqueness and superiority, and consider countries of application in anticipation of global expansion. The IP division reports directly to the CEO and has access to information from all departments, including business management and R&D. A system that allows active intervention in the early stages of management and business strategies has become widespread. In addition, the IP department is also transferred to business divisions and concurrently works with information management in order to create synergy effects with other fields with expertise other than IP.

3. With three in-house designers, the brand design and trademark strategy are linked. In addition, the company licenses trademarks such as "Brain Health Care" at no cost, aiming to boost the resolution of medical issues that humanity will face in the future and to spread the concept of health care centered on brain health to society.

The key to the evaluation was the company's positioning of intellectual property as an important asset and its strategic use of it in its unique AI-based initiatives in the field of brain health care.

Comment from Mr. Hiroki Aoyama, Representative Director, Splink Corporation

Scene at the greeting speech by the representative of the award winners

We are very honored to receive the "Intellectual Property Merit Award. While the demand for accurate diagnosis of brain diseases is increasing, there is a serious shortage of doctors and specialists.

Last year saw the official approval of Japan's first drug to inhibit the progression of Alzheimer's disease, and there is no end to the number of innovations in drug discovery. Under such circumstances, the importance of accurate and early diagnosis in the field of brain diseases, which are difficult to diagnose, is increasing day by day. When considering the safe prescription of therapeutic drugs, it is important for companies like ours that develop diagnostic medical devices to promote their business while appropriately managing intellectual property to ensure a safe supply of products from the perspective of the Pharmaceutical Affairs Law and a stable supply of products/technology. Pharmaceutical affairs strategy and intellectual property strategy are inextricably linked, and research and development in a business-oriented manner is at the core of our business.

Splink will continue to integrate its intellectual property strategy and business strategy to further research and development and its implementation in society, and contribute to solving the issues of aging in the world with science and technology originating in Japan.

About Splink Corporation

With the vision of "Connecting all people, until the day we are all connected," we provide one-stop integrated solutions in the Brain Healthcare® area, including dementia, from early detection to diagnostic support.
Our main products are CQ test®, a unique cognitive function test that can easily measure cognitive function in healthy subjects; Brain Life Imaging®, an AI program that analyzes brain MRIs to measure and visualize the volume of the hippocampus, an area of the brain closely related to memory and learning, and provides an easy-to-understand report from the viewpoint of the examinee to promote awareness; and Braineer®, a brain image analysis program that quantifies and quantifies the degree of brain loss from brain MRIs to provide useful information for diagnosis and diagnostic support. Brain Life Imaging®" and "Braineer®," a brain image analysis program that provides useful diagnostic information by quantifying and quantifying the degree of brain loss from brain MRI, are our main products.

name of companySplink Corporation
EstablishmentJanuary 2017
Location4F WAW Akasaka 35th Kowa Building, 1-14-14 Akasaka, Minato-ku, Tokyo
representativeYuki Aoyama
Business OverviewBrain Health Care Business, Medical Device Program Business
uniform resouce locatorhttps://www.splinkns.com/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。